Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 13 Nov 2026

LUPIN, full dossier

Lupin partner Sandoz has launched RanluspecTM across Europe, excluding Germany, for the treatment of retinal and choroidal vascular diseases.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Lupin partner Sandoz has launched RanluspecTM across Europe, excluding Germany, for the treatment of retinal and choroidal vascular diseases.

indiatimes.com12 Nov 2026

Lupin's commercial partner, Sandoz, has launched the company's ranibizumab biosimilar Ranluspec across Europe, excluding Germany.

indiatimes.com12 Nov 2026

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.